Penalties Under ACA Tied to Drop in Medicare Readmission Rates

Share this content:
Penalties Under ACA Tied to Drop in Medicare Readmission Rates
Penalties Under ACA Tied to Drop in Medicare Readmission Rates

WEDNESDAY, Dec. 28, 2016 (HealthDay News) -- Passage of the Medicare Hospital Readmissions Reduction Program (HRRP) under the Affordable Care Act is associated with a more rapid decrease in 30-day risk-standardized readmission rates (RSRRs), according to a study published online Dec. 27 in the Annals of Internal Medicine.

Jason H. Wasfy, M.D., M.Phil., from Massachusetts General Hospital in Boston, and colleagues examined whether passage of the HRRP correlated with acceleration in improvement in 30-day RSRRs after hospitalization for acute myocardial infarction, congestive heart failure, or pneumonia. Data were included for 15,170,008 Medicare patients discharged alive from 2000 to 2013. Thirty-day readmission rates were assessed after hospitalization at hospitals stratified by hospital performance: highest performance (0 percent penalty), average performance (>0 percent and <0.50 percent penalty), low performance (≥0.5 percent and <0.99 percent penalty), and lowest performance (≥0.99 percent penalty).

The researchers found that, of the 2,868 hospitals serving 1,109,530 Medicare discharges annually, 30.1, 44.0, 16.8, and 9.0 percent were highest, average, low, and lowest performers, respectively. After passage of the law, an additional 67.6, 74.8, 85.4, and 95.1 readmissions per 10,000 discharges were averted per year in the highest-, average-, low-, and lowest-performance groups, respectively, after controlling for prelaw trends.

"After passage of the HRRP, 30-day RSRRs for myocardial infarction, heart failure, and pneumonia decreased more rapidly than before the law's passage," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »